AXSOME THERAPEUTICS INC. - COMMON STOCK

Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

10 مايو 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics Joins Mental Health America and other Advocacy Organizations in Raising Awareness and Providing Support for Mental Health During Mental Health Month

07 مايو 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics to Report First Quarter 2021 Financial Results on May 10, 2021

27 أبريل 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for AXS-05 for Treatment of Major Depressive Disorder

26 أبريل 2021 06:00:00 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

01 مارس 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics to Present at Upcoming Investor Conferences

19 فبراير 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021

16 فبراير 2021 07:00:02 بحسب Nasdaq GlobeNewswire